1. Home
  2. ICD-10-PCS
  3. XW043L7
  4. Share
  5. Feedback

ICD-10-PCS Code XW043L7

Introduction of Lifileucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
“Introduce Lifileucel in Central Vein, Perc, New Tech 7” for short

XW043L7 is a valid billable ICD-10 procedure code for Introduction of Lifileucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7. It is found in the 2024 version of the ICD-10 Procedure Coding System (PCS) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024.

Introduction involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Percutaneous approach involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

MS-DRG - Medicare Severity-Diagnosis Related Group
  • Pre MDC
    Chimeric antigen receptor (CAR) T-cell and other immunotherapies
    • DRG 018 - CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES

ICD-10-PCS code structure for XW043L7 — See Table View

1: Section X New Technology
2: Body System W Anatomical Regions
3: Root Operation 0 Introduction
4: Body Part 4 Central Vein
5: Approach 3 Percutaneous
6: Device L Erdafitinib Antineoplastic
7: Qualifier 7 New Technology Group 7

See also

  • The ICD-10-PCS Index of common procedure terms.
  • New Technology terms in the ICD-10-PCS Definitions table. These definitions may also provide additional explanation and/or examples within this section.
  • The ICD-10-PCS Device Aggregation Table containing entries that correlate a specific ICD-10-PCS device value with a general device value to be used in tables containing only general device values.